Erin R. Lansky

Vice President

Ms. Lansky joined RoundTable in September 2018 and works with the Pharmaceutical & Consumer Health and Medical Device transaction teams. In addition to identifying, evaluating, and executing new platform investments and portfolio company add-on transactions, she works with RoundTable’s investments in Renaissance Pharma, Revision Skincare / Goodier Cosmetics, and TIDI Products.

Prior to RoundTable, Ms. Lansky was a Vice President at BDT Capital Partners LLC, a merchant bank that provides advice and long-term capital through its affiliated investment funds to family- and founder-led businesses. Before BDT, she was an Associate on the Healthcare team at GTCR, and she began her career as an Investment Banking Analyst in the Mergers & Acquisitions group at Bank of America Merrill Lynch in New York.

Ms. Lansky received her AB, magna cum laude, with High Honors from Dartmouth College and was a member of Phi Beta Kappa.

PROFESSIONAL EXPERIENCE

  • Vice President, BDT Capital Partners LLC, August 2015 – 2018
  • Associate, GTCR LLC, June 2014 – July 2015
  • Analyst, Bank of America Merrill Lynch, June 2012 – June 2014


ACADEMIC BACKGROUND

  • Dartmouth College, A.B. with High Honors in Economics & Spanish/Hispanic Studies, Phi Beta Kappa, magna cum laude, 2012